Johnson & Johnson today announced promising new results from the Phase 1b/2 OrigAMI-4 study evaluating the efficacy and safety of subcutaneous (SC) amivantamab monotherapy in patients with human ...

SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, today announced positive topline results from the ...

State emergency management officials say they're facing funding challenges from the federal government that threaten the ...

A week of fractious back-and-forth between the U.S. and China drove the point home as Trump responded to new export controls ...

Thousands showed up to protest Donald Trump’s administration across the country on Saturday, with several taking place in the ...

Unlike the older generation, young professionals are investing in digital gold this Diwali season. Traditionally, Dhanteras ...

AI chipmaker Nvidia ($NVDA) continues to attract strong optimism from both investors and analysts, fueled by its dominant ...

Rachel Reeves acknowledged she was looking at potential tax rises and spending cuts to fill a black hole in her Budget which she said was partly ...

Physical AI equips machines with the ability to perceive, learn, and act in the real world by integrating AI algorithms with ...

For many investors, it is not just a trading window but a ritual of hope and renewal, a moment to invite prosperity for the ...

Discover why Truist Financial Corporation beat Q3 2025 estimates but faces a cautious outlook amid market uncertainties.

Not-so-Personal Computing For years, technological development has been driven by the desire to make computing more ...